INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aratana Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 23, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Aratana Therapeutics, Inc. ("Aratana" or the "Company") ...
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aratana Therapeutics, Inc. (PETX) and Lead Plaintiff Deadline - April 7, 2017
NEW YORK, NY / ACCESSWIRE / March 23, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Aratana Therapeutics, Inc. ("Aratana" or the ...
- Motley Fool•2 days ago
It's best to wait until the price is right.
PETX : Summary for Aratana Therapeutics, Inc. - Yahoo Finance
Aratana Therapeutics, Inc. (PETX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||5.09 x 2200|
|Ask||5.10 x 600|
|Day's Range||4.99 - 5.22|
|52 Week Range||4.85 - 10.73|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-5.32|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|